Recent studies have suggested that tattoos, chemical hair straighteners and even hot tea might be a problem. Here’s what an ...

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

Complementary nature of these two immunotherapies leads to excellent 17.6-month median Overall Survival in head and neck ...

Serenity Health held its 4th annual Fentanyl Awareness Day event on Tuesday, April 29. Janice Thigpen is the first woman ...

FDA meeting requested following Phase IIb trial showing median overall survival of 17.6 months without chemotherapy Immutep ...

Jack David was on his family’s annual trip to Priest Lake, Idaho, when he woke up in the middle of that vacation and felt a ...

Laryngeal cancer is a serious condition that can impact your ability to speak, swallow and in some cases, breathe. Each year, ...

Low-dose computed tomography is more sensitive than chest radiography in detecting lung metastases or second primary lung cancer in patients with HNSCC.

Despite a congressional mandate to expand care for veterans, internal Veterans Affairs messages obtained by ProPublica paint ...

Reducing the dose of radiation to nodal regions is safe and does not impact the risk of recurrence in patients with head and neck cancer, a study suggests.

There is a positive association between exposure to at least 1 head/neck CT scan and the risk for pediatric brain tumors.

Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head ...